We are live on ! Find out more
PC

PointState Capital Portfolio holdings

AUM $7.9B
1-Year Est. Return 42.31%
This Fund
S&P 500
This Quarter Est. Return
+13.2%
1 Year Est. Return
+42.31%
3 Year Est. Return
+142.91%
5 Year Est. Return
+261%
10 Year Est. Return
+1,945.58%
AUM
$5.87B
AUM Growth
+$356M
Cap. Flow
-$28.2M
Cap. Flow %
-0.48%
Top 10 Hldgs %
37.62%
Holding
149
New
49
Increased
32
Reduced
27
Closed
36

Top Buys

Rank Stock Value
1
RTX icon
RTX Corp
RTX
+$191M
2
UAL icon
United Airlines
UAL
+$156M
3
DAL icon
Delta Air Lines
DAL
+$150M
4
VER
VEREIT, Inc.
VER
+$127M
5
FNF icon
Fidelity National Financial
FNF
+$120M

Top Sells

Rank Stock Value
1
ABBV icon
AbbVie
ABBV
+$382M
2
MPC icon
Marathon Petroleum
MPC
+$200M
3
PXD
Pioneer Natural Resource Co.
PXD
+$162M
4
LNG icon
Cheniere Energy
LNG
+$143M
5
TEVA icon
Teva Pharmaceuticals
TEVA
+$128M

Sector Composition

Rank Sector Weight
1 Healthcare 24.02%
2 Industrials 20.86%
3 Energy 10.85%
4 Consumer Discretionary 8.31%
5 Technology 7.31%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
DISH
76
DELISTED
DISH Network Corp.
DISH
$12.7M 0.22%
174,200
-16,300
-9% -$1.1M
AEGR
77
DELISTED
Aegerion Pharmaceuticals
AEGR
$12.6M 0.21%
600,000
+190,000
+46% +$4.79M
NOC icon
78
Northrop Grumman
NOC
$76B
$12.1M 0.21%
81,900
+55,100
+206% +$7.55M
LBTYA icon
79
Liberty Global Class A
LBTYA
$3.59B
$12M 0.2%
+289,174
New +$11.1M
KITE
80
DELISTED
Kite Pharma, Inc.
KITE
$11.1M 0.19%
192,500
+167,500
+670% +$7.05M
PAM icon
81
Pampa Energía
PAM
$4.57B
$10.3M 0.18%
1,031,655
+1,012,855
+5,388% +$10.7M
XRT icon
82
State Street SPDR S&P Retail ETF
XRT
$457M
$10.1M 0.17%
+210,000
New +$9.42M
IPXL
83
DELISTED
Impax Laboratories, Inc.
IPXL
$9.5M 0.16%
300,000
+150,000
+100% +$4.39M
PCYC
84
DELISTED
PHARMACYCLICS INC
PCYC
$9.07M 0.15%
+74,150
New +$9.48M
PRTA icon
85
Prothena Corp
PRTA
$448M
$8.3M 0.14%
400,000
-150,000
-27% -$3.13M
JPM icon
86
JPMorgan Chase
JPM
$916B
$8.13M 0.14%
+130,000
New +$7.82M
W icon
87
Wayfair
W
$11.8B
$7.94M 0.14%
+400,000
New +$9.6M
KERX
88
DELISTED
Keryx Biopharmaceuticals Inc
KERX
$7.08M 0.12%
+500,000
New +$7.75M
BLUE
89
DELISTED
bluebird bio
BLUE
$6.88M 0.12%
5,790
-4,246
-42% -$2.84M
BLCM
90
DELISTED
Bellicum Pharmaceuticals, Inc.
BLCM
$5.76M 0.1%
+25,000
New +$5.36M
ALDR
91
DELISTED
Alder Biopharmaceuticals
ALDR
$5.09M 0.09%
175,000
-200,000
-53% -$3.59M
EQIX icon
92
PUT
Equinix
EQIX
$99.4B
$4.88M 0.08%
21,500
– –
PRQR icon
93
ProQR Therapeutics
PRQR
$244M
$3.76M 0.06%
+173,500
New +$2.63M
KPTI icon
94
Karyopharm Therapeutics
KPTI
$155M
$3.74M 0.06%
6,667
– –
SRPT icon
95
Sarepta Therapeutics
SRPT
$1.64B
$3.62M 0.06%
250,000
-475,000
-66% -$8.04M
HES
96
DELISTED
Hess
HES
$3.55M 0.06%
48,100
– –
TSN icon
97
CALL
Tyson Foods
TSN
$21.5B
$3.53M 0.06%
88,000
– –
GT icon
98
Goodyear
GT
$2.09B
$2.65M 0.05%
+92,900
New +$2.3M
CORV
99
DELISTED
Correvio Pharma Corp. Ordinary Shares (Canada)
CORV
$2.31M 0.04%
+250,000
New +$2.1M
CQH
100
DELISTED
Cheniere Energy Partners LP Holdings LLC
CQH
$2.16M 0.04%
95,823
-123,300
-56% -$2.81M
2 3
4
5 6

Similar funds

CIP
Champlain Investment Partners Burlington, Vermont $7.88B AUM 6.82% 1-Year Est. Return
IMRF
Illinois Municipal Retirement Fund Oak Brook, Illinois $7.86B AUM 24.45% 1-Year Est. Return
SF
Summit Financial Parsippany, New Jersey $7.85B AUM 20.99% 1-Year Est. Return
CMTU
Capital Markets Trading (UK) London, United Kingdom $7.95B AUM 85.98% 1-Year Est. Return
PGFC
Peapack-Gladstone Financial Corp Bedminster, New Jersey $7.82B AUM 21.06% 1-Year Est. Return
EGM
Engineers Gate Manager New York $8B AUM 17.32% 1-Year Est. Return
PA
Pinnacle Associates New York $7.78B AUM 45.07% 1-Year Est. Return
MT
Midwest Trust Overland Park, Kansas $8.02B AUM 23.54% 1-Year Est. Return

PointState Capital's Q4 2014 Portfolio in Review

As of Q4 2014, PointState Capital held 149 positions worth $5.87B, up 6.4% from $5.52B the previous quarter. Its ten largest holdings account for 38% of the portfolio.

PointState Capital's Q4 2014 filing shows 49 new, 32 increased, 27 reduced and 36 closed positions. Its largest new stake was RTX Corp: 2,807,127 shares worth $203M. The largest sale was AbbVie, an estimated $382M.

By sector, the portfolio is most concentrated in Healthcare at 24% of assets, down from 29% a quarter earlier, followed by Industrials and Energy.

  • PointState Capital's largest Q4 2014 buy was RTX Corp: 2,807,127 shares worth $203M.
  • PointState Capital added most to United Airlines in Q4 2014, an estimated $156M increase.
  • PointState Capital's biggest Q4 2014 reduction was AbbVie, cutting an estimated $382M.
  • PointState Capital fully exited Marathon Petroleum in Q4 2014, selling an estimated $200M.
  • PointState Capital's ten largest holdings make up 38% of its $5.87B portfolio in Q4 2014.
  • PointState Capital opened 49 new positions and closed 36 in Q4 2014.
  • PointState Capital's portfolio value rose 6.4% quarter-over-quarter to $5.87B.

Based on PointState Capital's 13F filing for Q4 2014, filed 17 Feb 2015.